<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03652506</url>
  </required_header>
  <id_info>
    <org_study_id>2011-KAEK-25 2018/06-27</org_study_id>
    <nct_id>NCT03652506</nct_id>
  </id_info>
  <brief_title>The Impact of Anterior Abdominal Wall Tissue Oxygenation During Pneumoperitoneum of Regional Anesthesia Methods</brief_title>
  <official_title>Investigation the Effect of Regional Anesthesia Methods Anterior Abdominal Wall Tissue Oxygenation on Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bursa Yüksek İhtisas Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bursa Yüksek İhtisas Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During laparoscopic surgery, the abdomen is inflated with carbon dioxide for abdominal
      imaging and increased intraabdominal pressure affects intraabdominal structures and abdominal
      wall.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators aimed to investigate the effects of regional anesthesia methods
      administered during laparoscopic cholecystectomy on abdominal wall oxygenation and
      postoperative pain scores.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 28, 2018</start_date>
  <completion_date type="Anticipated">December 28, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 28, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>prospective,randomized</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participant, Outcomes Assessor</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>rso2</measure>
    <time_frame>peroperative 2 hours</time_frame>
    <description>The regional oxymetry probe will be placed in the abdominal region of the umbilicus in the middle clavicular line</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>Visual Analog Scale was used for pain.Pain intensity was measured using 0-10 cm visual analogue scale (VAS). (0=no pain, 10=intolerable pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tramadol consumption</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>tramadol consumption with PCA (patient-controlled analgesia ) device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>additional analgesic use</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>additional analgesic use (paracetamol and NSAİD)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Laparoscopy</condition>
  <condition>Abdominal Wall</condition>
  <condition>Regional Anesthesia</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The regional oxymetry probe will be placed in the abdominal region of the umbilicus in the middle clavicular line before the disease operation begins.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group E</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thoracic Epidural block +The regional oxymetry probe will be placed in the abdominal region of the umbilicus in the middle clavicular line before the disease operation begins.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Q</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided unilateral anterior Quadratus Lumborum block +The regional oxymetry probe will be placed in the abdominal region of the umbilicus in the middle clavicular line before the disease operation begins.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>regional oxymetry probe</intervention_name>
    <description>The regional oxymetry probe will be placed in the abdominal region of the umbilicus in the middle clavicular line before the disease operation begins.</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group E</arm_group_label>
    <arm_group_label>Group Q</arm_group_label>
    <other_name>abdominal wall tissue oxygenation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Quadratus Lumborum block</intervention_name>
    <description>Ultrasound guided unilateral anterior Quadratus Lumborum block with 20 ml %0.25 bupivacaine+The regional oxymetry probe will be placed in the abdominal region of the umbilicus in the middle clavicular line before the disease operation begins.</description>
    <arm_group_label>Group Q</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thoracic Epidural block</intervention_name>
    <description>Thoracic Epidural block with 20 ml %0.25 bupivacaine+The regional oxymetry probe will be placed in the abdominal region of the umbilicus in the middle clavicular line before the disease operation begins.</description>
    <arm_group_label>Group E</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who were in the American Society of Anesthesiologists (ASA) I-III class

          -  Underwent laparoscopic cholecystectomy

        Exclusion Criteria:

          -  Previous surgeon surgeon

          -  Local anesthetic allergy,

          -  Bleeding is a diathesis disorder

          -  Mental impairment,

          -  Allergic to the drugs used,

          -  Patients who are not reluctant to participate in the study,

          -  Presence of infection in the block area,

          -  Patients whose body mass index is over 30
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Korgün Ökmen, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>korgün Ökmen, M.D</last_name>
    <phone>05057081021</phone>
    <email>korgunokmen@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Burcu Metin Ökmen, M.D</last_name>
    <phone>05057081020</phone>
    <email>burcumetinokmen@gmail.com</email>
  </overall_contact_backup>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 19, 2018</study_first_submitted>
  <study_first_submitted_qc>August 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2018</study_first_posted>
  <last_update_submitted>August 28, 2018</last_update_submitted>
  <last_update_submitted_qc>August 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bursa Yüksek İhtisas Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Korgün Ökmen</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

